Atlanta, Georgia 2021-10-25 11:21:01 –
Curant, Inc. owns pharmacies in Smyrna, Georgia and St. Petersburg, Florida. Is much higher than the “normal and customary” prices charged to other patients, especially the government, to resolve allegations of violating fraudulent claims law with its owners and affiliates. ..
“Pharmacies cannot overcharge government medical programs while offering cheaper prices to others, in breach of the payer’s agreement,” said Kurt Erskine, acting U.S. federal prosecutor. .. “Such actions undermine efforts to protect government health plans and keep costs low.”
“The FBI is committed to protecting the health and safety of American taxpayers,” said Chris Hacker, a special agent at the FBI Atlanta. “Healthcare providers who take shortcuts to increase financial returns must be held liable for inappropriate and illegal claims that increase health care costs.”
“This settlement acts as a warning to companies and individuals seeking access to the Pentagon’s (DoD) medical program,” said Cynthia A. Bruce, Special Agent for the Department of Defense Inspector General. Survey Services (DCIS), South East Field Office. “DCIS and our research partners are committed to fully investigating allegations of fraud, waste and abuse that endanger the valuable medical resources of our military families.”
Curant Health Georgia LLC and Curant Health Florida LLC, owned by Patrick Dunham, Scott Zepp, Marc O’Connor, and Pankajkumar Patel (collectively “Curant”), have dispensed complex analgesic and scar creams to TRICARE beneficiaries. TRICARE provides health insurance to military members and their families. To keep costs down, TRICARE prohibits pharmacies from charging more than the “normal” price defined as the retail price of medicines in cash transactions. Despite this ban, the government claims that between 2013 and 2015, Curant charged TRICARE a much higher price for compound cream than it offered to cash-paying patients.
The government also paid kickbacks to third-party marketers for doctors to arrange for doctors to send prescriptions to Curant between 2013 and 2015, paying patients to increase sales. Claimed to have abandoned and filed a claim with TRICARE for the compound. Creams that weren’t medically needed, and after it knew them, couldn’t return the overpayment received from TRICARE.
The civil settlement resolves a lawsuit filed below in the US District Court in the Northern District of Georgia by Dennis Long, a former pharmacist at Curant’s Georgia Pharmacy. qui tam, Or the provisions of whistleblowers in the Fraudulent Claims Act. United States exrel. Longv. CurantHealthGeorgia, LLC, et al., Civil Litigation Number 1: 19-CV-3954-AT. Under the False Claims Act, civilians can file false claims on behalf of the United States and share the government’s recovery. Mr Long will receive $ 805,000 from the settlement. Curant also pays legal fees.
Atlanta pharmacy to pay $4.6 million to settle False Claims Act allegations regarding compound medications Source link Atlanta pharmacy to pay $4.6 million to settle False Claims Act allegations regarding compound medications